GLOW blend dosage chart for injection

The first row is convention from vendor pages, so read the source column before comparing amounts. The second row is there so you can see what each peptide is dosed at on its own, because one draw of the blend gives you all three in whatever split the vendor chose. Vendor pages give one pattern for the blend, so the second row isn't a second GLOW option, it's the three peptides at their own common amounts. Background on the blend lives on the GLOW blend page, and the skin peptide in it has its own GHK-Cu dosage chart.

GLOW is sold as a premixed freeze-dried powder for injection under the skin, and the vials we track are almost all 70 mg. You mix it with bacteriostatic water, which is sterile water with a preservative so one vial can be drawn from more than once. The table shows the units to draw on a U-100 syringe, which holds 100 units in 1 mL, for 1, 2 and 3 mL of water.

What one draw delivers. On a 50:10:10 split, 71.4 percent of the vial is GHK-Cu and 14.3 percent each is BPC-157 and TB-500. The split holds whatever water you add, and only the strength changes. A 1 mg draw is about 714 mcg of GHK-Cu with 143 mcg each of the others, and a 2 mg draw is about 1,429 mcg with 286 mcg each.

Unit figures are rounded to the nearest tenth. A few units is hard to read on a syringe. More water makes each draw bigger and easier to measure, so 3 mL is the easier choice for a 70 mg vial.

For any other vial, water or amount, the reconstitution calculator does the same math.

Once a day. That's the pattern on vendor pages, and we found no study that tests it for the blend or for the three peptides together.

Eight to twelve weeks, then a break. That's the course described most often, and we couldn't find where the length or the break came from. People who describe skin changes put them at weeks 8 to 12, which is reported experience, not a finding.

A mixed vial goes on a 28-day clock in the fridge the day water goes in, however much of it gets used. A 70 mg vial is more than one person finishes in that time. At 1 mg a day only 28 mg gets used and 42 mg expires, and at 2 mg a day 56 mg gets used and 14 mg expires. For 12 weeks of daily dosing that's three 70 mg vials mixed one at a time, 210 mg bought, whichever amount you pick.

Because the split is uneven, the blend doesn't match the amounts each peptide is run at alone. At 1 to 2 mg a day you get 143 to 286 mcg of BPC-157 in a single daily injection. The most common pattern on the BPC-157 dosage chart is 250 to 500 mcg per injection, once or twice a day, so the blend sits at or below the low end. You get 1 to 2 mg of TB-500 a week, against 4 to 5 mg a week in the twice-weekly pattern on the TB-500 dosage chart.

GHK-Cu is the part that carries the weight of the vial, and its own page gives 1 to 2 mg a day, with up to 5 mg described less often, and at 1 to 2 mg of blend you get about 0.7 to 1.4 mg of GHK-Cu, the low end of that range. Vendor pages describe the blend as one injection in place of three. Adding KPV turns it into the KLOW blend, which is sold as its own product. We found no study of any of these combinations.

These are reported experiences, not findings from a study of research vials.

Redness or a lump where you injected. People report it, and if it doesn't settle between daily doses they rotate the spot or stop.

A metallic taste. People report it occasionally and link it to the copper in GHK-Cu. Some people stop if it carries on.

Nausea or a headache in the first week. People report it early in a course, and they usually stop if it doesn't pass.

Nothing visible after 12 weeks. People often stop here. Skin changes slowly, so some people take photos in the same light at the start to judge it.